Cover Image
Market Research Report
Product code 
1053761

Sleep Apnea Diagnostics Market by Product (Polysomnography Devices, Actigraphy Systems, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

Published: | Allied Market Research | 207 Pages | Delivery time: 2-3 business days

Price

Back to Top
Sleep Apnea Diagnostics Market by Product (Polysomnography Devices, Actigraphy Systems, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030
Published: November 24, 2021
Allied Market Research
Content info: 207 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The global sleep apnea diagnostics market was valued at $290.50 million in 2020, and is projected to reach $545.09 million by 2030, registering a CAGR of 6.7% from 2021 to 2030.

Obstructive sleep-disordered breathing (SDB) is a syndrome of upper airway dysfunction during sleep that is characterized by snoring and/or increased respiratory effort secondary to greater upper airway resistance and pharyngeal collapsibility. Obstructive sleep apnea (OSA) is a sleep disorder that results in significant decrease or cessation of airflow in the presence of breathing effort. If the brain does not send the signals needed to breathe, the condition is referred to as central sleep apnea. Around 85-90% of OSA patients are estimated to remain undiagnosed that demonstrates the unmet medical needs. Sleep apnea diagnostic products evaluate the breathing and other body functions of patients during sleep, thereby boosting the demand for these devices to combat sleep apnea disease. The general characteristic of Obstructive Sleep Apnea is the increased collapsibility of the upper airway during sleep resulting in markedly reduced (hypopnea) or absent (apnea) airflow at the nose and/or mouth which is usually accompanied by oxyhemoglobin desaturation and is typically terminated by a brief micro-arousal. Repeated episodes of apnea lead to a sustained reduction in oxyhemoglobin saturation and sleep fragmentation with diminished amounts of slow-wave and rapid eye movement (REM) sleep. The major predisposing factor for sleep apnea is excess body weight. It has been estimated that 58% of moderate to severe OSA is attributable to obesity.

The global sleep apnea diagnostic market is anticipated to register notable growth due to increase in geriatric population as well as a surge in prevalence of sedentary lifestyle disorders such as obesity and diabetes, as well as considerable increase in awareness about sleep apnea. Furthermore, technical developments to make products more convenient for users as well as a notable increase in sleep apnea diseases are driving market expansion. However, the market is expected to be hampered by the high cost of sleep apnea treatment tools, restricted reimbursement for these devices, and low patient compliance. On the contrary, the progressive rise in popularity of home healthcare equipment is expected to provide attractive development opportunities for the global market in the near future.

The global sleep apnea diagnostics market is segmented into product, end user, and region. Depending on product, the market is fragmented into polysomnography (PSG) devices, actigraphy systems, respiratory polygraph, sleep apnea screening device, oximeter, and others. On the basis of end user, it is bifurcated into sleep laboratory & hospital and home healthcare. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. supply chains were disrupted due to restrictions on trade of pharmaceutical ingredients and products across countries. The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. In the initial days of the COVID-19 pandemic 2020, some countries were in lockdown. They banned trade with other nations and enforced travel restrictions, resulting in decline in diagnostics and surgical procedures in the first half of 2020. In addition, COVID 19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas of the sleep apnea diagnostics market. The banned trade with other nations and enforced travel restrictions, resulting in decline in diagnostics and surgical procedures in the first half of 2020. According to the study published in the British Journal of Surgery, around 28.4 million elective procedures were cancelled or postponed in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19. There has been a significant reduction in hospitals and sleep laboratory-based diagnosis of sleep apnea. Overall impact of the COVID-19 pandemic on the global sleep apnea market was recorded to be negative, owing to the factors such as sleep lab were closed due to lockdown in many countries. However, this situation is expected to change post COVID-19 pandemic in the coming years.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the sleep apnea diagnostics market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

BY PRODUCT

  • Polysomnography device (PSG)
  • Clinical PSG device
  • Ambulatory PSG device
  • Sleep apnea screening device
  • Actigraphy monitoring device
  • Respiratory polygraph
  • Oximeter
  • Fingertip oximeter
  • Handheld oximeter
  • Wrist-worn oximeter
  • Tabletop oximeter

BY END USER

  • Hospitals & sleep laboratories
  • Homecare settings

By REGION

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Cadwell Industries Inc.
  • DeVilbiss Healthcare LLC
  • Koninklijke Philips N.V.
  • Medtronic PLC.
  • Mindray Medical International Limited
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Resmed Inc.
  • Smiths Group Plc. (Smiths Medical)
  • SomnoMedics GmbH
Product Code: A04312

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
    • 3.2.3.Top winning strategies, by year, 2019-2021
    • 3.2.4.Top winning strategies, by developments, 2019-2021(%).
    • 3.2.5.Top winning strategies, by company, 2019-2021.
    • 3.2.6.Top player positioning, 2020
  • 3.3.Porter's five force analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Rise in prevalence of obesity across the globe
      • 3.4.1.2.Increase in number of employees working in shifts and under stressful work conditions
      • 3.4.1.3.Technological advancements in sleep apnea diagnostic devices
    • 3.4.2.Restraints
      • 3.4.2.1.High cost associated with sleep apnea diagnostic devices
      • 3.4.2.2.Lack of awareness among patients regarding sleep apnea
    • 3.4.3.Opportunity
      • 3.4.3.1.Untapped markets in developing economies
  • 3.5.COVID-19 impact analysis on sleep apnea diagnostics market

CHAPTER 4:SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Polysomnography device (PSG)
    • 4.2.1.Key trends and opportunities
    • 4.2.2.List of distributors
    • 4.2.3.Market size and forecast, by region
    • 4.2.4.Market analysis, by country
    • 4.2.5.Clinical PSG
      • 4.2.5.1.1.Market size and forecast
    • 4.2.6.Ambulatory PSG
      • 4.2.6.1.1.Market size and forecast
  • 4.3.Sleep apnea screening device
    • 4.3.1.Key trends and opportunities
    • 4.3.2.List of ditributors
    • 4.3.3.Market size and forecast
    • 4.3.4.Market analysis, by country
  • 4.4.Actigraphy monitoring device
    • 4.4.1.Key trends and opportunities
    • 4.4.2.List of distributors
    • 4.4.3.Market size and forecast
    • 4.4.4.Market analysis, by country
  • 4.5.Respiratory polygraph
    • 4.5.1.Key trends and opportunities
    • 4.5.2.List of distributors
    • 4.5.3.Market size and forecast
    • 4.5.4.Market analysis, by country
  • 4.6.Oximeter
    • 4.6.1.Key trends and opportunities
    • 4.6.2.List of distributors
    • 4.6.3.Market size and forecast, by region
    • 4.6.4.Market analysis, by country
    • 4.6.5.Fingertip oximeter
      • 4.6.5.1.1.Market size and forecast
    • 4.6.6.Handheld oximeter
      • 4.6.6.1.1.Market size and forecast
    • 4.6.7.Wrist-worn oximeter
      • 4.6.7.1.1.Market size and forecast
    • 4.6.8.Tabletop oximeter
      • 4.6.8.1.1.Market size and forecast

CHAPTER 5:SLEEP APNEA DIAGNOSTICS MARKET, BY END USER

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Hospitals & sleep laboratories
    • 5.2.1.List of distributors
    • 5.2.2.Market size and forecast
    • 5.2.3.Market analysis, by country
  • 5.3.Home care settings
    • 5.3.1.List of distributors
    • 5.3.2.Market size and forecast
    • 5.3.3.Market analysis, by country

CHAPTER 6:SLEEP APNEA DIAGNOSTICS MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key trends and opportunities
    • 6.2.2.List of distributors
    • 6.2.3.North America market size and forecast, by country
      • 6.2.3.1.U.S. market size and forecast, by product
      • 6.2.3.2.U.S. market size and forecast, by end user
      • 6.2.3.3.Canada market size and forecast, by product
      • 6.2.3.4.Canada market size and forecast, by end user
      • 6.2.3.5.Mexico market size and forecast, by product
      • 6.2.3.6.Mexico market size and forecast, by end user
    • 6.2.4.North America market size and forecast, by product
    • 6.2.5.North America market size and forecast, by end user
  • 6.3.Europe
    • 6.3.1.Key trends and opportunities
    • 6.3.2.List of distributors
    • 6.3.3.Europe market size and forecast, by country
      • 6.3.3.1.Germany market size and forecast, by product
      • 6.3.3.2.Germany market size and forecast, by end user
      • 6.3.3.3.UK market size and forecast, by product
      • 6.3.3.4.UK market size and forecast, by end user
      • 6.3.3.5.France market size and forecast, by product
      • 6.3.3.6.France market size and forecast, by end user
      • 6.3.3.7.Italy market size and forecast, by product
      • 6.3.3.8.Italy market size and forecast, by end user
      • 6.3.3.9.Spain market size and forecast, by product
      • 6.3.3.10.Spain market size and forecast, by end user
      • 6.3.3.11.Rest of Europe market size and forecast, by Product
      • 6.3.3.12.Rest of Europe market size and forecast, by end user
    • 6.3.4.Europe market size and forecast, by product
    • 6.3.5.Europe market size and forecast, by end user
  • 6.4.Asia-Pacific
    • 6.4.1.Key trends and opportunities
    • 6.4.2.List of distributors
    • 6.4.3.Asia-Pacific market size and forecast, by country
      • 6.4.3.1.Japan market size and forecast, by product
      • 6.4.3.2.Japan market size and forecast, by end user
      • 6.4.3.3.China market size and forecast, by product
      • 6.4.3.4.China market size and forecast, by end user
      • 6.4.3.5.Australia market size and forecast, by product
      • 6.4.3.6.Australia market size and forecast, by end user
      • 6.4.3.7.India market size and forecast, by product
      • 6.4.3.8.India market size and forecast, by end user
      • 6.4.3.9.Rest of Asia-Pacific market size and forecast, by product
      • 6.4.3.10.Rest of Asia-Pacific market size and forecast, by end user
    • 6.4.4.Asia-Pacific market size and forecast, by product
    • 6.4.5.Asia-Pacific market size and forecast, by end user
  • 6.5.LAMEA
    • 6.5.1.Key market trends and opportunities
    • 6.5.2.List of distributors
    • 6.5.3.LAMEA market size and forecast, by country
      • 6.5.3.1.Brazil market size and forecast, by product
      • 6.5.3.2.Brazil market size and forecast, by end user
      • 6.5.3.3.South Africa market size and forecast, by product
      • 6.5.3.4.South Africa market size and forecast, by end user
      • 6.5.3.5.Saudi Arabia market size and forecast, by product
      • 6.5.3.6.Saudi Arabia market size and forecast, by end user
      • 6.5.3.7.Rest of LAMEA market size and forecast, by product
      • 6.5.3.8.Rest of LAMEA market size and forecast, by end user
    • 6.5.4.LAMEA market size and forecast, by product
    • 6.5.5.LAMEA market size and forecast, by end user

CHAPTER 7:COMPANY PROFILES

  • 7.1.Cadwell Industries Inc.
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating business segments
    • 7.1.4.Product portfolio
    • 7.1.5.Business performance
    • 7.1.6.Key strategic moves and developments
  • 7.2.Devilbiss Healthcare
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Product portfolio
  • 7.3.Koninklijke Philips N.V. (Philips)
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating business segments
    • 7.3.4.Product portfolio
    • 7.3.5.Business performance
  • 7.4.Medtronic Plc.
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segment
    • 7.4.4.Product portfolio
    • 7.4.5.Business performance
  • 7.5.Mindray Medical International Limited
    • 7.5.1.Company overview
    • 7.5.2.Operating business segment
    • 7.5.3.Product portfolio
  • 7.6.Natus Medical Incorporated
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product portfolio
    • 7.6.5.Business performance
  • 7.7.Nihon Kohden Corporation
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Product portfolio
    • 7.7.5.Business performance
  • 7.8.Resmed Inc.
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating business segment
    • 7.8.4.Product portfolio
    • 7.8.5.Business performance
    • 7.8.6.Key strategic moves and developments
  • 7.9.Smith's Group Plc. (Smiths Medical)
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product portfolio
    • 7.9.5.Business performance
  • 7.10.SOMNOmedics Gmbh
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Product portfolio
    • 7.10.5.Business performance

LIST OF TABLES

  • TABLE 01.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 02.SLEEP APNEA DIAGNOSTICS MARKET FOR POLYSOMNOGRAPHY DEVICE (PSG) BY REGION, 2020-2030($MILLION)
  • TABLE 03.SLEEP APNEA DIAGNOSTICS MARKET FOR SLEEP APNEA SCREENING DEVICE, BY REGION, 2020-2030($MILLION)
  • TABLE 04.SLEEP APNEA DIAGNOSTICS MARKET FOR ACTIGRAPHY MONITORING DEVICE, BY REGION, 2020-2030($MILLION)
  • TABLE 05.SLEEP APNEA DIAGNOSTICS MARKET FOR RESPIRATORY POLYGRAPHS, BY REGION, 2020-2030($MILLION)
  • TABLE 06.SLEEP APNEA DIAGNOSTICS MARKET FOR OXIMETER, BY REGION, 2020-2030($MILLION)
  • TABLE 07.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 08.SLEEP APNEA DIAGNOSTICS MARKET FOR HOSPITALS & SLEEP LABORATORIES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.SLEEP APNEA DIAGNOSTICS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.SLEEP APNEA DIAGNOSTICS MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 12.U.S. SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 13.U.S. SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 14.CANADA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 15.CANADA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 16.MEXICO. SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 17.MEXICO SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 18.NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 19.NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 20.EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 21.GERMANY SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 22.GERMANY SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 23.UK SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 24.UK SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 25.FRANCE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 26.FRANCE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 27.ITALY SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 28.ITALY SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 29.SPAIN SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 30.SPAIN SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 31.REST OF EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 32.REST OF EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 33.EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 34.EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 35.ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 36.JAPAN SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 37.JAPAN SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 38.CHINA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 39.CHINA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 40.AUSTRALIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 41.AUSTRALIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 42.INDIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 43.INDIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 44.REST OF ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 45.REST OF ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 46.ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 47.ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 48.LAMEA ALLERY END USER MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 49.BRAZIL SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 50.BRAZIL SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 51.SOUTH AFRICA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 52.SOUTH AFRICA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 53.SAUDI ARABIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 54.SAUDI ARABIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 55.REST OF LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 56.REST OF LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 57.LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 58.LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 59.CADWELL: COMPANY SNAPSHOT
  • TABLE 60.CADWELL: OPERATING SEGMENTS
  • TABLE 61.CADWELL: PRODUCT PORTFOLIO
  • TABLE 62.CADWELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 63.DEVILBISS: COMPANY SNAPSHOT
  • TABLE 64.DEVILBISS: PRODUCT PORTFOLIO
  • TABLE 65.PHILIPS: COMPANY SNAPSHOT
  • TABLE 66.PHILIPS: OPERATING SEGMENTS
  • TABLE 67.PHILIPS: PRODUCT PORTFOLIO
  • TABLE 68.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 69.MEDTRONIC: OPERATING SEGMENT
  • TABLE 70.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 71.MINDRAY: COMPANY SNAPSHOT
  • TABLE 72.MINDRAY: OPERATING SEGMENTS
  • TABLE 73.MINDRAY: PRODUCT PORTFOLIO
  • TABLE 74.NATUS: COMPANY SNAPSHOT
  • TABLE 75.NATUS: OPERATING SEGMENTS
  • TABLE 76.NATUS: PRODUCT PORTFOLIO
  • TABLE 77.NIHON KOHDEN: COMPANY SNAPSHOT
  • TABLE 78.NIHON KOHDEN: OPERATING SEGMENTS
  • TABLE 79.NIHON: PRODUCT PORTFOLIO
  • TABLE 80.RESMED: COMPANY SNAPSHOT
  • TABLE 81.RESMED: OPERATING SEGMENTS
  • TABLE 82.RESMED: PRODUCT PORTFOLIO
  • TABLE 83.RESMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84.SMITHS: COMPANY SNAPSHOT
  • TABLE 85.SMITHS: OPERATING SEGMENTS
  • TABLE 86.SMITHS: PRODUCT PORTFOLIO
  • TABLE 87.SOMNOMEDICS: COMPANY SNAPSHOT
  • TABLE 88.SOMNOMEDICS: OPERATING SEGMENTS
  • TABLE 89.SOMNOMEDICS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP PLAYER POSITIONING, 2020
  • FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08.MODERATE INTENSITY OF RIVALRY
  • FIGURE 09.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 10.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR POLYSOMNOGRAPHY DEVICE (PSG) BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 11.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR CLINICAL POLYSOMNOGRAPHY DEVICE (PSG), 2020-2030($MILLION)
  • FIGURE 12.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR AMBULATORY POLYSOMNOGRAPHY DEVICE (PSG), 2020-2030($MILLION)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR SLEEP APNEA SCREENING DEVICE, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR ACTIGRAPHY MONITORING DEVICE, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF OTHER SLEEP APNEA DIAGNOSTICS MARKET FOR RESPIRATORY POLYGRAPH, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR OXIMETER, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 17.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR FINGERTIP OXIMETER DEVICE, 2020-2030($MILLION)
  • FIGURE 18.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR HANDHELD OXIMETER DEVICE, 2020-2030($MILLION)
  • FIGURE 19.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR WRIST-WORN OXIMETER DEVICE, 2020-2030($MILLION)
  • FIGURE 20.GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR TABLETOP OXIMETER DEVICE, 2020-2030($MILLION)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR HOME CARE SETTINGS, BY COUNTRY 2020 & 2030 (%)
  • FIGURE 23.CADWELL: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 24.CADWELL: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 25.PHILIPS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 26.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 27.PHILIPS: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 28.MEDTRONIC: NET SALES, 2020 ($MILLION)
  • FIGURE 29.MEDTRONIC: REVENUE SHARE PER SEGMENT 2020(%)
  • FIGURE 30.MEDTRONIC: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 31.NATUS: NET SALES, 2020 ($MILLION)
  • FIGURE 32.NATUS: REVENUE SHARE BY PRODUCT, 2020 (%)
  • FIGURE 33.NATUS: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 34.NIHON KOHDEN: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 35.NIHON KOHDEN: REVENUE SHARE BY SEGMENT, 2020(%)
  • FIGURE 36.NIHON KOHDEN: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 37.RESMED: NET SALES, 2019-2020 ($MILLION)
  • FIGURE 38.RESMED: REVENUE SHARE BY SEGMENT, 2020 ($MILLION)
  • FIGURE 39.RESMED: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 40.SMITHS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 41.SMITHS: REVENUE SHARE BY DIVISION, 2020 (%)
  • FIGURE 42.SMITHS: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 43.SOMNOMEDICS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 44.SOMNOMEDICS: REVENUE SHARE BY DIVISION, 2020 (%)
  • FIGURE 45.SOMNOMEDICS: REVENUE SHARE BY REGION, 2020 (%)